TERAPIA CELULAR Y MEDICINA REGENERATIVA
Tel Aviv Sourasky Medical Center
Tel Aviv, IsraelPublications en collaboration avec des chercheurs de Tel Aviv Sourasky Medical Center (1)
2021
-
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 13, pp. 1426-1436